#AI In Oncology Sales market

[sanskruti01]

Generative AI in Healthcare Market to Grow at an 35.1% CAGR Till 2032!

The global Generative AI in Healthcare Market worth USD 1.07 billion in 2023 is likely to be USD 21.74 billion by 2032, growing at a 35.1% CAGR between 2023 and 2032.

According to the stats published by World Health Organization (WHO), approximately 1.28 million adults (between 30 and 79 years of age) have hypertension. Of these, as little as 42% of adults are diagnosed and treated correctly and the remaining population is unaware of this condition. The majority of this population resides in low to middle-income countries of the world. Despite this substantial number of untreated cases, the rising awareness among doctors and the general population regarding health illnesses associated with hypertension is expected to drive the demand for the required devices.

Download White Paper@ https://www.towardshealthcare.com/personalized-scope/5069

A recent report provides crucial insights along with application based and forecast information in the Global Generative AI in Healthcare Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this Market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Generative AI in Healthcare Market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the Market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Report Objectives

To define, describe, and forecast the global Generative AI in Healthcare Market based on product, and region

To provide detailed information regarding the major factors influencing the growth of the Market (drivers, opportunities, and industry-specific challenges)

To strategically analyze microMarkets1 with respect to individual growth trends, future prospects, and contributions to the total Market

To analyze opportunities in the Market for stakeholders and provide details of the competitive landscape for Market leaders

To forecast the size of Market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2

To strategically profile key players and comprehensively analyze their product portfolios, Market shares, and core competencies3

To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Generative AI in Healthcare Market

Companies and Manufacturers Covered

The study covers key players operating in the Market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Generative AI in Healthcare Market are included as given below:

Generative AI in Healthcare Market Key Players:

Syntegra

NioyaTech

Saxon

IBM Watson

Microsoft Corporation

Google LLC

Tencent Holdings Ltd.

Neuralink Corporation

OpenAI

Oracle

Market Segments :

By Application

Clinical

Cardiovascular

Dermatology

Infectious Disease

Oncology

Others

System

Disease Diagnosis

Telemedicine

Electronic Health Records

Drug Interaction

By Function

AI-Assisted Robotic Surgery

Virtual Nursing Assistants

Aid Clinical Judgment/Diagnosis

Workflow & Administrative Tasks

Image Analysis

By End User

Hospitals & Clinics

Clinical Research

Healthcare Organizations

Diagnostic Centers

Others

By Geography

North America

Europe

Asia-Pacific

Latin America

Middle East and Africa

Contact US -

Towards Healthcare

Web: https://www.towardshealthcare.com/

You can place an order or ask any questions, please feel free to contact at 

Email:  sales@towardshealthcare.com

About Us

We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

[datastringconsulting]

Top 5 Countries in Immuno Oncology Clinical Trials Market: Spotlight on U.S., Germany, and UK

Industry revenue for Immuno Oncology Clinical Trials is estimated to rise to $35.0 billion by 2035 from $10.0 billion of 2024. U.S., Germany, and UK are the top 3 markets and followed by Japan and China. These major five combinely holds substantial demand share and compounded annual sales growth of market players in these countries are expected to range between 10.9% and 14.5% annually for period 2025 to 2035.

Industry Leadership and Strategies

North America and Asia-Pacific are the two most active and leading regions in the market. With challenges like regulatory scrutiny and compliance issues and recruitment and retention of participants, Immuno Oncology Clinical Trials market’s eco system from clinical trial design and planning / biological sample collection / drug development and manufacturing to clinical research and data analysis, is expected to evolve & expand further. Companies such as Merck & Co. Inc, Bristol-Myers Squibb, AstraZeneca plc, Johnson & Johnson, Pfizer Inc, Novartis International AG, Gilead Sciences Inc, Eli Lilly and Company, Hoffmann-La Roche AG, Sanofi.

Industry Opportunities

Precision Medicine in Immuno Oncology Clinical Trials: Advancements in technology have led to the rise of precision medicine shaping immuno oncoclogy trials in a significant way by tailoring cancer treatment to address specific genetic mutations within tumors This innovative approach in immuno oncoclogy opens up new avenues, for creating better and more streamlined cancer treatments that could potentially transform the existing market dynamics.

AI Integration in Immuno Oncology Clinical Trials: Artificial Intelligence is making its way into industries and its role in immuno oncology clinical trials is becoming apparent . By using AI technology for drug discovery and development, in trials can speed up the process and cut down on expenses and time. If this new approach becomes widely accepted in the field of immuno oncology clinical trials market it could simplify procedures and improve the markets growth potential.

About DataString Consulting

DataString Consulting assist companies in strategy formulations & roadmap creation including TAM expansion, revenue diversification strategies and venturing into new markets; by offering in depth insights into developing trends and competitor landscapes as well as customer demographics. Our customized & direct strategies, filters industry noises into new opportunities; and reduces the effective connect time between products and its market niche.

DataString Consulting offers complete range of market research and business intelligence solutions for both B2C and B2B markets all under one roof. DataString’s leadership team has more than 30 years of combined experience in Market & business research and strategy advisory across the world. Our Industry experts and data aggregators continuously track & monitor high growth segments within more than 15 industries and 60 sub-industries.

[amolsblogs]

3D Imaging Surgical Solutions Market: Trends, Forecast, and Competitive Analysis to 2035

3D Imaging Surgical Solutions Market Overview 2025-2035

The global 3D Imaging Surgical Solutions Market Growth is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2035. By 2035, the market's forecasted revenue is expected to reach USD 17.16 billion, following an average growth trajectory. In 2025, the market size is estimated to be valued at USD 8.74 billion.

The 3D imaging surgical solution market is growing due to advanced 3D image sensors, urbanization, and demand from sectors like automotive, manufacturing, media, and entertainment. The integration of AI with 3D imaging devices and opportunities in retail and eCommerce further drive growth. Government investments in healthcare, innovative technologies, an aging population, and rising chronic diseases requiring advanced diagnostics are boosting adoption and sales.

Request PDF Sample Copy of Report @ https://wemarketresearch.com/reports/request-free-sample-pdf/3d-imaging-surgical-solutions-market/1641

Opportunities for Growth

The market forecast for 3D imaging surgical solutions highlights significant growth potential driven by their ability to enhance safety for surgeons and staff, as well as improve visualization for intricate and minimally invasive procedures. In recent years, the adoption of advanced technologies has been steadily increasing in developing economies, contributing to substantial revenue growth in these regions.

3D imaging surgical technologies have proven invaluable across various surgical platforms, enabling precise assessments and outcomes. Key external drivers of growth include new product launches, the rising popularity of minimally invasive surgeries, optimized supply chains, and strategic mergers and acquisitions by major players in the 3D imaging surgical solutions market.

Principal Advantages for Participants

The study offers a thorough examination of the size of the global market for 3D imaging surgical solutions, as well as current trends and projections for the future to help identify potential areas for investment.

It provides market research from 2024 to 2035, which should help the concerned parties take advantage of the current industry prospects.

A thorough examination of the area aids in comprehending the local market, facilitating strategic business planning, and identifying opportunities that are already available.

The competitive prognosis for the growth of the worldwide 3D Imaging Surgical Solutions market is determined by a detailed analysis of the profiles and growth strategies of the major players.

Ask for Customization @ https://wemarketresearch.com/customization/3d-imaging-surgical-solutions-market/1641

Market Challenges

High Costs of Equipment

The initial investment and maintenance costs of 3D imaging systems are significant, posing a barrier to widespread adoption, particularly in developing regions.

Lack of Skilled Professionals

Operating 3D imaging equipment requires specialized training. The shortage of skilled technicians and radiologists is a challenge that healthcare providers must address.

Data Privacy Concerns

The increasing digitization of patient data raises concerns about data security and privacy. Ensuring compliance with regulatory standards is essential to build trust in these technologies.

Market Segments:

By Technology

Computed Tomography

Magnetic Resonance Imaging

Ultrasound Imaging

Optical Imaging

Cone Beam Computed Tomography

By Application

Orthopedic Surgery

Cardiovascular Surgery

Neurosurgery

Oncology Surgery

Spine Surgery

Others

By End-use

Hospitals

Ambulatory Surgical Centers

Research Institutions

Diagnostic Imaging Centers

Future Outlook

The future of the 3D imaging surgical solutions market looks promising, with continued advancements in AI and imaging technologies. Emerging trends such as augmented reality (AR) and virtual reality (VR) integration into surgical workflows will further enhance the precision and effectiveness of 3D imaging systems. Additionally, the increasing focus on personalized medicine is likely to drive the adoption of these solutions across various surgical specialties.

Market Regional Analysis:

North America: Dominates the global 3D Imaging Surgical Solutions market, led by the U.S., thanks to advanced healthcare infrastructure, technological innovation, and high R&D investments.

Europe: Significant share driven by strong healthcare systems, rising expenditure, and minimally invasive procedure focus, with Germany, France, and the UK leading.

Asia-Pacific: Fastest-growing region, fueled by expanding healthcare, rising chronic diseases, and growing investments, with China, India, and Japan as key contributors.

Middle East & Africa: Increasing demand for advanced technologies due to healthcare spending, infrastructure upgrades, and government initiatives.

Latin America: Steady growth supported by rising healthcare expenditure, technology adoption, and infrastructure advancements.

Top Leading Key Companies Involved in this research report are:

GE Healthcare

Siemens Healthineers

Philips Healthcare

Stryker Corporation

Medtronic

Olympus Corporation

Karl Storz

Zimmer Biomet

Brainlab AG

Intuitive Surgical

Canon Medical Systems

Fujifilm Holdings Corporation

Carestream Health

Hologic, Inc.

3D Systems, Inc.

Commonly Asked Questions?

Q1. How much is the 3D Imaging Surgical Solutions market research worth overall?

Q2. What time frame would the market report forecast?

Q3. How much will the 3D Imaging Surgical Solutions market be worth in 2021?

Q4. In the market study for 3D Imaging Surgical Solutions, which base year is used?

Q5. Does the study provide a profile of 3D Imaging Surgical Solutions?

Q6. In the market for 3D Imaging Surgical Solutions, which leading firms have the largest market shares?

Q7. What are emerging nations' market values and growth percentages?

Q8. Which major trends emerge from the market analysis on 3D Imaging Surgical Solutions?

Click Here for Purchase Report @ https://wemarketresearch.com/purchase/3d-imaging-surgical-solutions-market/1641?license=single

Conclusion

The 3D imaging surgical solutions market is set to play a pivotal role in transforming surgical practices worldwide. By addressing current challenges and leveraging technological advancements, this market has the potential to significantly improve patient outcomes and redefine the standards of surgical care. As stakeholders across the healthcare ecosystem continue to invest in and adopt these innovative solutions, the future of surgery will undoubtedly be shaped by the power of 3D imaging.

About We Market Research:

WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets.

[businessitblog]

Top MNC Companies in Pune

Pune, the cultural capital of Maharashtra, has emerged as a key hub for multinational corporations (MNCs) in India. The city's growing infrastructure and well-educated workforce have attracted many MNCs across various sectors such as IT, automotive, finance, manufacturing, and pharmaceuticals. 

In this article, we will delve into some of the top MNC companies in Pune, their key features, ratings, and how to apply for jobs in these companies at different levels, from entry-level to senior positions.

Explore top companies 

1. Infosys Technologies

Industry: IT Services Key Features:

Infosys is a leading provider of IT consulting and services, offering solutions to clients globally.

The company provides a wide range of services, including digital transformation, cloud computing, and AI.

Infosys places a strong emphasis on employee development with regular training programs and career growth opportunities. Rating: 4.2/5 (Glassdoor)

How to Apply:To apply for a job at Infosys, visit their careers page, where you can search for job openings based on job functions, locations, and experience levels. For senior roles, applicants need to submit detailed CVs, followed by interviews.

2. Cognizant Technology Solutions

Industry: IT and Consulting Key Features:

Cognizant offers digital and technology solutions globally, specializing in software engineering, data analytics, and consulting.

The company is known for its work culture, employee satisfaction, and high-performance standards.

It provides opportunities in various fields including engineering, IT, and business consulting. Rating: 4.0/5 (Glassdoor)

How to Apply:You can apply for positions at Cognizant by visiting their career page, where you can filter vacancies by domain and location. Candidates generally go through an online assessment followed by technical and HR interviews.

3. Tata Consultancy Services (TCS)

Industry: IT and Consulting Key Features:

TCS is one of the largest IT services providers in India, specializing in consulting, software development, and digital transformation.

The company offers various career development and upskilling programs.

TCS is renowned for its work-life balance and employee benefits. Rating: 4.1/5 (Glassdoor)

How to Apply:You can apply to TCS via their recruitment portal, where you need to submit an application. The process includes an online test followed by a technical interview and HR interview. TCS also recruits from colleges for entry-level positions.

4. Siemens India

Industry: Engineering and Technology Key Features:

Siemens is a global leader in electrical engineering and electronics, specializing in automation, digitalization, and electrification.

Known for its innovative technologies and sustainable practices.

Offers careers in engineering, IT, and project management. Rating: 4.3/5 (Glassdoor)

How to Apply:Job vacancies at MNC companies in pune Siemens are listed on their career page. For mid-management roles, applicants submit resumes and undergo online tests. Senior roles require direct applications, references, and experience verification.

5. Pfizer India

Industry: Pharmaceuticals Key Features:

Pfizer is a global leader in biopharmaceuticals, focusing on oncology, immunology, and rare diseases.

The company is known for its research and development initiatives in the pharmaceutical sector.

Roles available include R&D, marketing, sales, and regulatory affairs. Rating: 4.2/5 (Glassdoor)

How to Apply:Visit Pfizer’s career portal to apply for jobs in your preferred domain. Entry-level roles generally require a basic qualification and an online application, while senior positions require industry experience and leadership skills.

6. HDFC Bank

Industry: Banking and Financial Services Key Features:

HDFC Bank is one of India's largest private sector banks, offering a range of banking services to individuals and businesses.

Known for its enthusiastic corporate culture and competitive pay scales.

Offers opportunities in finance, customer service, operations, and digital banking. Rating: 4.1/5 (Glassdoor)

How to Apply:HDFC Bank's career page allows you to apply for positions across various domains. Applicants for mid-management roles submit resumes, followed by aptitude tests and interviews. Senior positions involve formalized application procedures and interview rounds.

7. Accenture

Industry: Consulting and IT Services Key Features:

Accenture is a leader in consulting, technology services, and outsourcing.

Offers a wide range of opportunities in strategy, consulting, technology, and operations.

Known for its training programs and career growth prospects. Rating: 4.3/5 (Glassdoor)

How to Apply:To apply to MNC companies in Pune at  Accenture, visit their career portal and submit applications for open positions. Entry-level roles involve a technical interview, while senior roles require case studies and leadership discussions.

8. Capgemini

Industry: IT and Consulting Key Features:

Capgemini is a global IT services and consulting company, providing technology-driven business solutions.

Known for its inclusive work culture, diversity, and employee well-being.

Offers roles in IT, consulting, and business transformation. Rating: 4.0/5 (Glassdoor)

How to Apply:Apply through Capgemini's website, where you can search for jobs. Entry-level candidates must pass online tests followed by interviews. Senior positions require knowledge of business processes and relevant industry experience.

9. L'Oréal India

Industry: Cosmetics and Beauty Key Features:

L'Oréal is a leader in beauty and cosmetics, known for innovation and strong brands.

Offers career opportunities in product development, marketing, and sales.

Famous for nurturing creativity and talent development. Rating: 4.2/5 (Glassdoor)

How to Apply:Visit L'Oréal's careers page to apply for jobs in product development, marketing, or sales. Entry-level applicants submit resumes, while senior candidates must demonstrate experience and industry knowledge.

10. IBM India

Industry: IT and Consulting Key Features:

IBM is a global technology company known for its cloud computing and AI services.

Renowned for its innovative solutions and inclusive work culture.

Offers a comprehensive learning and development program. Rating: 4.1/5 (Glassdoor)

How to Apply:Job seekers can apply via IBM’s career website. Entry-level candidates must pass an online test, followed by technical and HR interviews. Senior roles require an updated CV, leadership experience, and high-level technical skills.

Application Process in MNCs from Entry-Level to Senior Positions

Entry-Level Positions:

For entry-level roles, applicants generally need a relevant degree or certification. The application process involves submitting a resume through the company’s career portal or job board. Candidates may need to take an online aptitude test, followed by interviews.

Mid-Level Jobs:

For mid-level roles, candidates need 3-5 years of relevant experience. The application process typically includes submitting a resume and going through detailed interviews, which may include technical tests or case studies. Leadership potential and industry experience are highly valued.

Senior-Level Jobs:

Senior roles require extensive experience, often 5-10 years. Applicants must submit an updated CV that highlights leadership roles and achievements. The process usually involves multiple interview rounds, including discussions on strategy, leadership, and industry expertise.

Conclusion

Pune offers a thriving ecosystem for MNC companies in Pune, providing numerous job opportunities across industries like IT, finance, healthcare, automotive, and cosmetics.

Whether you're starting your career or looking for a more senior role, the city has options at every level. By following the application processes outlined by these top companies, you can find a role that aligns with your skills and career goals.

[rohitpalan]

Advanced (3D/4D) Visualization Systems Market Surges: Revenue Reaches USD 711.1M in 2022, Expected to Hit USD 1,139.9M by 2033

The global Advanced (3D/4D) Visualization Systems Market demonstrated remarkable growth in 2022, with a total revenue of US$ 711.1 million. This sector is poised for a promising future, as it is projected to expand at a CAGR of 4.5% from 2023 to 2033. By the end of the forecast period in 2033, the market is expected to reach a substantial US$ 1,139.9 million.

Key Takeaways:

The Advanced (3D/4D) Visualization Systems Market is on a growth trajectory, projected to reach US$ 1,139.9 million by 2033, driven by factors such as advanced medical imaging adoption and AI integration.

North America leads the market, while Asia-Pacific presents significant growth opportunities.

Challenges include high implementation costs and data security concerns.

Emerging technologies like VR and AR offer promising prospects for market players.

Drivers and Opportunities:

The growth of the Advanced (3D/4D) Visualization Systems Market can be attributed to several key drivers. The increasing adoption of advanced medical imaging techniques and the rising demand for real-time data visualization in healthcare are significant factors fueling this market’s growth. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in 3D/4D visualization systems is enhancing diagnostic capabilities and driving market expansion.

Moreover, opportunities abound as the market taps into emerging technologies, including virtual reality (VR) and augmented reality (AR), which are revolutionizing industries such as healthcare, aerospace, and automotive. These innovations are opening new avenues for market players to develop cutting-edge visualization solutions.

Competitive Landscape – Regional Trends:

The Advanced (3D/4D) Visualization Systems Market boasts a competitive landscape with several key players vying for dominance. Regional trends reveal varying market dynamics. North America currently leads the market due to its advanced healthcare infrastructure and substantial investments in research and development. Meanwhile, Asia-Pacific is witnessing rapid growth, driven by increasing healthcare expenditure and a burgeoning demand for advanced visualization technologies in countries like China and India.

Restraints:

Despite its growth prospects, the market faces certain challenges. The high cost of implementing advanced visualization systems and concerns related to data security are restraining factors. Additionally, the complexity of integrating these systems into existing healthcare workflows poses a challenge for market adoption.

Region-wise Insights – Category-wise Insights:

North America remains the dominant region in the Advanced (3D/4D) Visualization Systems Market, with the United States leading the way. The region benefits from a robust healthcare infrastructure and significant investments in research and development.

Europe is witnessing steady growth, with countries like Germany and the United Kingdom contributing significantly to the market. The region’s focus on improving healthcare outcomes through advanced visualization technologies is driving market expansion.

Asia-Pacific is emerging as a lucrative market, driven by the increasing healthcare expenditure in countries like China and India. The demand for 3D/4D visualization systems in diagnostics and treatment planning is on the rise.

Advanced (3D/4D) Visualization Systems Outlook by Category

By Platform, Advanced (3D/4D) Visualization Systems Demand is segmented as:

Ultrasound

MRI

CT

PET

By End User, Advanced (3D/4D) Visualization Systems Outlook is segmented as:

Hospitals

Diagnostic Laboratories

Academic and Research

By Application, Advanced (3D/4D) Visualization Systems Sales are segmented as:

Cardiology

Oncology

Neurology

By Region, Advanced (3D/4D) Visualization Systems Sales are segmented as:

North America

Latin America

Europe

South Asia

East Asia

Oceania

The Middle East and Africa (MEA)

[grapheneai]

Benchmarking in Healthcare: Deciding Smarter with AI

In the world of healthcare, the adoption of Artificial Intelligence (AI) is reshaping how pharmaceutical companies make critical decisions. AI’s ability to sift through substantial amounts of data and generate insights with unparalleled speed is becoming a key differentiator.  

One of the most significant areas where AI is proving invaluable is benchmarking in healthcare, where companies can compare their performance against competitors using advanced analytics and unbiased feedback. 

AI’s Role in Healthcare Insights 

For pharmaceutical companies, insights are no longer about numbers—they are about understanding the patient experience, prescriber preferences, and the healthcare provider’s perspective on therapies. Traditional data sources like surveys and reports are being enhanced by GrapheneAI, which processes vast amounts of data using Natural Language Processing (NLP) and statistical models. Complex healthcare feedback is turned into understandable insights that drive smarter decision-making. 

GrapheneAI’s ability to provide unbiased insights from healthcare providers, patients, and even non-users gives pharmaceutical companies a clearer understanding of the market landscape. This understanding is crucial when it comes to answering critical business questions about the effectiveness of existing treatments or the potential of upcoming therapies. 

Benchmarking in Healthcare with AI: Why It Matters? 

Benchmarking in healthcare research traditionally involves comparing performance metrics across organizations to gauge effectiveness, efficiency, and overall impact. However, AI-enhanced benchmarking takes this concept further by leveraging external feedback sources and synthesizing them with internal company data. This advanced form of benchmarking allows organizations to: 

Understand Awareness and Perceptions 

Healthcare research involves gathering data on awareness, beliefs, drivers, and barriers to treatment amongst both HCPs as well as patients. AI helps to aggregate and analyze these factors, whether it is for rare diseases, oncology, or chronic conditions. 

Evaluate User Experience 

Combining internal patient data with external feedback provides a holistic view of how users perceive and experience products. AI tools help track patient journeys, from diagnosis to treatment adherence, offering real-time insights into where therapy may be excelling or lagging. 

Uncover Competitive Intelligence 

AI can track what patients, prescribers, and non-users are saying about your brand and your competitors in real-time. Through sophisticated sentiment analysis, companies can better understand market perceptions and brand reputation, converting them into actionable intelligence. 

Competitive Benchmarking in Healthcare: How It Works? 

Pharmaceutical companies are always looking for ways to outperform their competition, especially in highly competitive therapeutic areas. AI-driven competitive benchmarking allows companies to monitor key performance indicators (KPIs) in real-time. Here is how it works: 

1. Combining Internal and External Data 

By combining proprietary company data (such as sales, prescription rates, or clinical outcomes) with AI-analyzed external feedback (user reviews, social media sentiment, discussion forums, reactions to scientific publications), companies get a comprehensive view of their position in the market. 

2. Identifying Drivers of Success 

AI can pinpoint which factors contribute most to a product being rated highly in each category. For example, in oncology, patients might value efficacy over side effects, while in chronic disease management, ease of use may be a bigger priority. AI helps identify and weigh these factors, revealing actionable insights. 

3. Real-Time Market Positioning 

AI systems can provide continuous feedback on how a company’s product is performing against its competitors in terms of perception, prescription habits, and patient outcomes. Companies can see where they lead and where they fall behind, enabling quick adjustments to marketing or product strategies. 

4. Proactive Decision-Making 

With AI-enhanced benchmarking in healthcare, companies can anticipate changes in market dynamics or patient preferences, allowing for proactive strategy development rather than reactive fixes. 

Uncovering Insights for Business Growth 

At the heart of AI-powered benchmarking in healthcare is the ability to translate unbiased opinions into actionable insights. This can provide pharmaceutical companies with a competitive edge, offering visibility into what patients and providers value most and how their brand is perceived in comparison to competitors. Armed with this knowledge, businesses can tailor their strategies to meet market demands more effectively. 

Additionally, these insights can guide product development, optimize marketing campaigns, and improve the patient experience by aligning product offerings more closely with what the market needs. 

Decide Faster with Benchmarking in Healthcare 

Pharmaceutical companies that embrace AI-driven benchmarking will be better equipped to understand their place in the market, adapt to emerging trends, and, most importantly, make smarter, data-driven decisions that lead to improved patient outcomes and business success. In a competitive landscape where the margin for error is slim, AI is not just an advantage—it is a necessity. 

Contact us at GrapheneAI to benchmark not just on financial or operational metrics but also on the quality of care, patient satisfaction, and market perception. 

[omshinde5145]

Image-guided Radiation Therapy (IGRT) Market Share, Sales Channels and Overview Till 2030

The Image-guided Radiation Therapy (IGRT) Market is expected to grow from USD 1.7 billion in 2023-e to USD 2.4 billion by 2030, at a CAGR of 5.3% during the forecast period. Image-Guided Radiation Therapy (IGRT) is an advanced form of radiation therapy that uses imaging techniques to precisely target cancer cells. The image-guided radiation therapy (IGRT) market is expected to grow significantly due to the ability of IGRT to deliver precise doses at the site of action and improve patient outcomes with reduced time of therapy. The accuracy of radiation therapy is increased when cutting-edge imaging technologies are incorporated into the treatment plan. This is especially crucial when treating tumors in motion-prone areas such as the prostate or lungs that are close to important structures.

IGRT is a medical procedure used in radiation oncology to target malignant tumors with therapeutic radiation with the least amount of damage to the surrounding healthy tissues. The integration of imaging technologies with the planning and delivery of radiation therapy treatment is the fundamental component of IGRT. This guarantees that, even in cases where the tumor position varies as a result of factors such as organ motion, anatomical changes in the patient, or respiratory motion, the radiation is precisely targeted to the tumor.

Download a Sample Copy of This Report- https://intentmarketresearch.com/request-sample/image-guided-radiation-therapy-market-3030.html

The IGRT market is influenced by several key factors:

Technological Advancements:

Continuous innovation in imaging and radiation delivery systems is driving the IGRT market forward. Enhanced imaging techniques, such as cone-beam CT, MRI, and PET scans, are enabling more precise tumor localization and treatment planning.

Integration of artificial intelligence (AI) and machine learning (ML) in IGRT systems is further optimizing treatment accuracy and efficiency. AI-powered algorithms can predict tumor movements and adjust radiation doses in real-time, ensuring optimal treatment outcomes.

Rising Cancer Prevalence:

The global burden of cancer is increasing, with millions of new cases diagnosed each year. This rise in cancer incidence is fueling the demand for advanced treatment options like IGRT.

According to the World Health Organization (WHO), the global cancer burden is expected to reach 27.5 million new cases by 2040. This surge underscores the critical need for effective and precise treatments, making IGRT a vital component of modern oncology.

Increased Healthcare Spending:

Governments and healthcare organizations are investing heavily in advanced medical technologies to improve cancer care. This increased funding is facilitating the adoption of IGRT systems in hospitals and cancer treatment centers worldwide.

Public and private healthcare insurers are recognizing the long-term benefits of IGRT in terms of improved patient outcomes and reduced healthcare costs, leading to broader reimbursement policies and greater accessibility.

Growing Awareness and Acceptance:

Awareness campaigns and educational initiatives are highlighting the benefits of IGRT among patients and healthcare providers. As more people become informed about the advantages of this technology, the demand for IGRT is steadily rising.

Professional organizations and regulatory bodies are endorsing IGRT as a standard practice in radiation therapy, further driving its adoption.

Market Segmentation

The IGRT market can be segmented based on technology, application, end-user, and region:

Technology:

Cone-Beam Computed Tomography (CBCT)

Electronic Portal Imaging Devices (EPID)

MRI-guided Radiation Therapy

Positron Emission Tomography (PET)

Application:

Lung Cancer

Prostate Cancer

Breast Cancer

Head and Neck Cancer

Others

End-User:

Hospitals

Ambulatory Radiotherapy Centers

Cancer Research Institutes

Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Get Customization on this Report: https://intentmarketresearch.com/ask-for-customization/image-guided-radiation-therapy-market-3030.html

Future Prospects

The future of the IGRT market looks promising, driven by ongoing research and development, technological innovations, and increasing adoption of precision medicine. Key trends to watch in the coming years include:

Advancements in Imaging Technology:

Continuous improvements in imaging modalities will enhance the accuracy and efficacy of IGRT. High-resolution imaging and real-time monitoring will become more sophisticated, allowing for even more precise targeting of tumors.

Integration of AI and ML:

The integration of AI and ML will revolutionize IGRT by enabling adaptive radiation therapy. AI algorithms will predict tumor responses, adjust treatment plans dynamically, and minimize radiation exposure to healthy tissues.

Personalized Cancer Treatment:

Precision medicine will play a crucial role in IGRT, tailoring treatments to individual patients based on genetic profiles, tumor characteristics, and treatment responses. This personalized approach will improve treatment outcomes and reduce side effects.

Global Expansion:

The IGRT market will expand globally, with emerging economies adopting advanced cancer treatment technologies. Increased healthcare infrastructure and government support will drive market growth in regions like Asia-Pacific and Latin America.

Conclusion

Image-Guided Radiation Therapy (IGRT) represents a significant leap forward in cancer treatment, offering unparalleled precision and effectiveness. The IGRT market is poised for substantial growth, driven by technological advancements, rising cancer prevalence, increased healthcare spending, and growing awareness. As we look to the future, continued innovation and integration of cutting-edge technologies will further enhance the capabilities of IGRT, ultimately transforming the landscape of cancer care and improving the lives of countless patients worldwide.

[themarketupdate]

AI In Oncology Market Detailed Strategies, Competitive Landscaping and Developments for next 5 years

Latest added AI In Oncology Market research study by Archive Market Research offers detailed outlook and elaborates market review till 2030. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are Azra AI,IBM,Siemens Healthcare GmbH,Intel Corporation,GE HealthCare,NVIDIA Corporation,Digital Diagnostics Inc.,ConcertAI,Median Technologies,PathAI} etc.  Click for Free Sample Report + All Related Graphs & Charts https://archivemarketresearch.com/report/ai-in-oncology-market-2449/sample-report The AI In Oncology Market size was valued at USD 4.18 billion in 2023 and is projected to reach USD 24.74 billion by 2032, exhibiting a CAGR of 28.92 % during the forecasts period. The latest edition of this report you will be entitled to receive additional chapter / commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation. Each of the segment analysis table for forecast period also high % impact on growth. The Global AI In Oncology segments and Market Data Break Down are illuminated below: {"Component Type: Software Solutions, Hardware","Cancer Type: Breast Cancer, Lung Cancer"}

Have Any Questions Regarding Global AI In Oncology Market Report, Ask Our Experts@ https://archivemarketresearch.com/report/ai-in-oncology-market-2449/enquiry-before-buy This report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article, we can also provide customized report as per company’s specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.

More Reports:

 https://archivemarketresearch.com/reports/ai-in-oncology-market-2449  https://archivemarketresearch.com/reports/veterinary-software-market-2444 Contact US : Craig Francis (PR & Marketing Manager) Archive Market Research Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[jcmarchi]

Absci and AstraZeneca forge AI partnership to discover cancer treatments

New Post has been published on https://thedigitalinsider.com/absci-and-astrazeneca-forge-ai-partnership-to-discover-cancer-treatments/

Absci and AstraZeneca forge AI partnership to discover cancer treatments

.pp-multiple-authors-boxes-wrapper display:none; img width:100%;

Absci, a frontrunner in generative AI antibody discovery, has partnered with biopharmaceutical giant AstraZeneca to leverage AI in the quest for a novel cancer treatment.

This collaboration will capitalise on Absci’s Integrated Drug Creation platform—seamlessly integrating with AstraZeneca’s expertise in oncology, aiming to expedite the discovery of a potentially game-changing cancer therapy.

Under the agreement, Absci will deploy its pioneering generative AI technology to craft a therapeutic candidate antibody tailored for a specific oncology target. The collaboration encompasses an upfront commitment, substantial R&D funding, milestone payments, and royalties on future product sales.

Sean McClain, Founder & CEO of Absci, said: “AstraZeneca is a leader in developing novel treatments in oncology, and we are excited to collaborate with them to design a therapeutic candidate antibody with the potential to improve the lives of cancer patients.”

Absci’s Integrated Drug Creation platform combines generative AI and scalable wet-lab technologies, generating proprietary data by scrutinising millions of protein-protein interactions. This data fuels Absci’s proprietary AI models, facilitating the design of antibodies that are later validated through wet-lab experiments.

This accelerated approach, completing the entire cycle within approximately six weeks, enhances the probability of successful development outcomes for biologic drug candidates.

Puja Sapra, PhD, SVP of Biologics Engineering & Oncology Targeted Delivery at AstraZeneca, commented: “This collaboration is an exciting opportunity to utilise Absci’s de novo AI antibody creation platform to design a potential new antibody therapy in oncology.”

The announcement follows Absci’s recent publication on the design and validation of de novo antibodies using their state-of-the-art ‘zero-shot’ generative AI model.

The collaboration between Absci and AstraZeneca should further help to demonstrate how AI can be used to revolutionise drug discovery.

(Photo by National Cancer Institute on Unsplash)

See also: AI & Big Data Expo: AI’s impact on decision-making in marketing

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is co-located with Cyber Security & Cloud Expo and Digital Transformation Week.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.

Tags: absci, ai, artificial intelligence, astrazeneca, cancer, cancer therapy, cancer treatment, health, healthcare, treatment

[organicmarketresearch1]

Global Active Pharmaceutical Ingredients (API) Market 2022-2032

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson and Johnson are the top 5 manufacturers of industry.

The Global Active Pharmaceutical Ingredients API Market Size was estimated at USD 67774.47 million in 2021 and is projected to reach USD 127217.78 million by 2028, exhibiting a CAGR of 6.60% during the forecast period.

This report provides a deep insight into the global Active Pharmaceutical Ingredients API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

Download Free Sample Report

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredients API Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredients API market in any manner.

Global Active Pharmaceutical Ingredients API Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

•Teva

•Mylan

•DSM

•Aurobindo Pharma

•Aspen

•Novartis

•BASF

•Pfizer

•Huahai Pharmaceutical

•Hisun Pharmaceutical

•Sun Pharmaceutical Industries

•Zhejiang Medicine

•Dr. Reddy’s Laboratories

•Zhejiang NHU

•Bayer

•NCPC

•AbbVie

•Shandong Xinhua Pharmaceutical

•Northeast Pharm

•Harbin Pharmaceutical

•LKPC

Market Segmentation (by Type)

•Synthetic APIs

•Biotech APIs

Market Segmentation (by Application)

•CNS

•Cardiovascular

•Genitourinary/Hormonal Drugs

•Respiratory

•Rheumatology

•Diabetes

•Oncology

•Others

Geographic Segmentation

• North America (USA, Canada, Mexico)

• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

• South America (Brazil, Argentina, Columbia, Rest of South America)

• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study

• Neutral perspective on the market performance

• Recent industry trends and developments

• Competitive landscape & strategies of key players

• Potential & niche segments and regions exhibiting promising growth covered

• Historical, current, and projected market size, in terms of value

• In-depth analysis of the Active Pharmaceutical Ingredients API Market

• Overview of the regional outlook of the Active Pharmaceutical Ingredients API Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

• This enables you to anticipate market changes to remain ahead of your competitors

• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

• Provision of market value (USD Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredients API Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market’s Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter’s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

About Us:

Organic Market Research Business Consulting is a fast-growing Market Research organization which is helping organizations to optimize their end-to-end research processes and increase their profit margins.

Organic Market Research facilitates clients with syndicate research reports and customized research reports on 10+ industries with global as well as regional coverage.

Mob : +91 9319642100

Noida One Tower Sec 62 Noida 201301

Sales : sales@organicmarketresearch.com

Website : https://www.organicmarketresearch.com

[bigfandeer]

Artificial Intelligence for Drug Development and Discovery Market Expected to Reach US$2,015.1 Million by 2025

Overview

The AI in drug discovery market is projected to grow by US$2,015.1 Million by 2025 rapidly at a CAGR of 40.8% throughout the forecast period 2019 to 2025. Integration of AI and machine learning tools as well as huge investments drive the global AI in drug discovery market. These key growth drivers have incredibly helped the AI in drug discovery market and are estimated to boost the growth. Analysts studying the AI in drug discovery market have also shared growth projections in the AI in drug discovery market research report and have suggested AI in drug discovery market-based companies to develop growth strategies. The high cost of AI integration and lack of infrastructure are the challenges that companies across the AI in drug discovery market could face. The details covered in the AI in drug discovery market report cover all the aspects of the industry.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/9393

Market Segmentation

The global AI in the drug discovery market has been segmented based on product type, technology, indication, molecule type, application, and end-user. On the basis of product type, the market for AI in drug discovery is segmented based on software and services. Additionally, the market on the basis of molecule type, is segmented into large molecule and small molecule. The global market for AI in drug discovery is also covered based on the technology segment which is further split into machine learning, deep learning and others. On the basis of indication, the market for AI in drug discovery is segmented based on cardiovascular diseases, metabolic diseases, neurodegenerative diseases, immuno-oncology, and others. Additionally, the market on the basis of end-user, is segmented into contract research organizations and research centers and academic & government institutes, pharmaceutical & biotechnology companies. The market is further segmented based on application into candidate screening, de novo drug designing, drug optimization and repurposing and preclinical testing, target identification.

Factors like increasing number of cross-industry partnerships and discovery of new pharmaceuticals propel the AI in drug discovery market growth. The AI in drug discovery market performance has also been studied. The AI in drug discovery market report provides analysis of past and current trends. In addition to this, the AI in drug discovery market report offers detailed analysis of application, indication, molecule type, technology, product type, and end-user segments. The market segmental analysis provided in the AI in drug discovery market research report offers crucial details about the AI in drug discovery market based on the data and forecasts till 2025.

Regional Overview

The AI in drug discovery market report covers companies functional in the AI in drug discovery market spread across regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world. The regional analysis of the AI in drug discovery market can be found in the market research report. The North American AI in drug discovery market has several key players functioning in the United States, Canada, and Mexico. Europe has companies in the AI in drug discovery market across Germany, France, Spain, Italy, and the United Kingdom. The AI in drug discovery market of the Middle East, Africa, and other regions has also been studied by analysts. A detailed analysis of the AI in drug discovery market across India, China, and Japan in the Asia-Pacific region is also available for further study.

Competitive Landscape

The AI in drug discovery market is corroborated by improvement in the drug development. The population growth as well as increasing demand of AI in drug discovery market based solutions also accelerate the market growth. However, the AI in drug discovery market can be affected due to lack of developed infrastructure as well as high cost involved in deployment. The AI in drug discovery market research report covers all such factors assisting companies in the AI in drug discovery market to improve their plans and portfolio. The AI in drug discovery market research report also provides company profiles of major businesses. The AI in drug discovery market report highlights crucial details about organizations operating across North America, Europe, Asia-Pacific (APAC), and the rest of the world regional markets. The details available in the AI in drug discovery market report cover company strategies, revenue, company size, and mergers and acquisitions in the AI in drug discovery market. New entrants as well as established organizations can use the data from AI in drug discovery market report to further plan their strategies.

Industry News

ByteDance, the Chinese parent organization of TikTok, is joining the health sector as it aims to diversify a market that focuses on sales of ads and livestreaming. The firm, which is proud of content analytics, has begun to search talent in Mountain View, Shanghai and Beijing for AI drug exploration, its hiring page reveals.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[sanpdr1994]

Oncology Information Systems Market 2022 Production Capacity, Restring Drivers, Size and Landscape Outlook 2032

The Broadening Healthcare IT Industry Will Generate New Opportunity to Promote the Oncology Information System Market to USD 16.02 Billion by 2032. The oncology information system market has been divided into two segments: solutions and professional services. Solutions accounted for the majority of revenue i.e. 73.4%.

The oncology information system market is expected to expand at a 7.8% CAGR. The oncology information system market is expected to grow from USD 2.59 billion in 2022 to USD 5.48 billion by 2032.

The increasing incidence and prevalence of cancer, as well as the growing need to reduce the cost of cancer care, are driving the oncology information system market growth, as are the potential benefits offered by oncology information systems in cancer treatment, management, and planning.

The oncology information system market includes software and services used for comprehensive information and image management, which aids in the management and optimization of cancer patient profiles and treatment.

Leading oncology information system market players' sales and operating incomes have decreased as a result of COVID-19. Inventory was reduced as a result of tight production controls.

Get Sample PDF Of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15150

The rising incidence of cancer cases is one of the major factors driving the oncology information system market growth. There are a few other factors driving the oncology information system market key trends and opportunities, such as the growing need to reduce oncology care costs and the growing adoption of oncology information system along with electronic health records (EHR) and other oncology information systems.

A major impediment to implementing OIS solutions in hospitals is a lack of qualified resources influencing the oncology information system market future trends along with oncology information system market opportunities. Currently, the demand for healthcare IT professionals outnumbers supply in both developing and developed oncology information system market, including the United States and Europe.

Asia Pacific accounted for 17.8% of the oncology information system market. The Asia Pacific oncology information system market is expanding due to several factors, including rising cancer prevalence and increased investment in the implementation of IT solutions in healthcare settings which h influences the oncology information system market adoption trends.

KEY TAKEAWAYS:

The oncology information system market has been divided into two segments: solutions and professional services. The solutions segment accounted for the majority of revenue i.e. 73.4%.

The solutions segment is further subdivided into patient information systems and treatment planning systems, with the latter accounting for the lion's oncology information system market share.

Medical oncology accounted for the largest oncology information system market share of global revenue, accounting for 61.4% of total revenue.

In 2021, the North America regional oncology information system market had the highest oncology information system market share's revenue of 38.5%.

The software segment accounted for 83.6% of the product and service oncology information system market.

Radiation oncology accounted for 53.8% of the oncology information system market.

Asia Pacific accounted for 17.8% of the oncology information system market.

COMPETITIVE LANDSCAPE:

Key oncology information system market companies are primarily focused on incorporating technological innovation with the introduction of web-based oncology solutions and AI-based oncology information system solutions with the goal of improving the treatment regime, which is expected to positively impact oncology information system market growth in the near future.

Elekta AB, Accuray Inc., Varian Medical Systems, RaySearch Laboratories, Cerner Corp., BrainLab, Philips Healthcare, Prowess, Inc., DOSIsoft S.A., ViewRay Inc., MIM Software, and Flatiron are among the prominent players in the oncology information system market.

RECENT DEVELOPMENT:           

Varian Medical Systems, Inc. announced a USD 10.0 million investment and a strategic collaboration agreement with COTA, Inc., a curator of clinical data in the oncology sector, in 2020.

Siemens Healthineers (Germany) completed the acquisition of Varian Medical System in August 2021. (UK). The goal of this acquisition was to create a one-of-a-kind, highly integrated portfolio of oncology information system workflow.

Koninklijke Philips N.V. (The Netherlands) and Elekta (Sweden) will collaborate in June 2021 to develop advanced, comprehensive, and personalised cancer care through precision oncology information solutions.

McKesson Corporation (US) has launched Ontada, an oncology technology and insights business dedicated to advancing cancer research and care, in December 2020.

Key Segments 

By Product:

Solutions

Patient Information Systems

Treatment Planning Systems

Professional Services

By Application:

Medical Oncology

Radiation Oncology

Surgical Oncology

By Region:

North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Asia Pacific

Japan

China

India

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East & Africa

Saudi Arabia

South Africa

UAE

[meditech-insights]

Single-Cell Analysis Market is set to be driven by the expansion of Oncology and Life Science Research

Single-cell technologies allow the examination of differences between individual cells instead of the averaged signal obtained is the case of bulk samples.

Global Single-Cell Analysis Market is estimated at $2.1 Bn (2020) growing at a CAGR of 17.8% through 2020-2025. The expansion of oncology and life science research is the factor driving the market growth.

Single-cell analysis: A potential oncology research tool

Single-cell analysis is emerging as powerful tool for cancer research. It characterizes the molecular state of each tumor cell, enabling exploration of tumor heterogeneity, microenvironment cell-type composition, and cell state transitions that affect therapeutic response, particularly in the context of immunotherapy. The demand for products used in single-cell analysis is projected to increase due to the increased incidence of various forms of cancer and the expansion of cancer research projects.

“Bulk sequencing can explain the most common mutations in tumor, but single-cell DNA multi-omics offer insights on which mutations occur at single-cell level. Drug developers are increasingly using single-cell analysis to prioritize targets and pathways for new therapies, demonstrate therapeutic efficacy, and understand resistance mechanisms” - Global Research Head, Leading Pharmaceutical Company

Investor funding is providing impetus for single-cell technology

Single-cell analysis has become a vital tool for scientific research. Investors are providing funding to companies that are developing products or solutions for single-cell analysis, citing the potential for advancement.

For instance,

In November 2021, Singleron Biotechnologies, a start-up company developing single-cell multi-omics products – raised $100 million to ramp up products development and augment international presence.

Further, in October 2021, Sphere Fluidics received $40 million to expand international sales activities for its single-cell analysis systems that use proprietary picodroplet technology.

Explore Premium Report on Single-Cell Analysis Market @ https://meditechinsights.com/single-cell-analysis-market/

Analysis of complex and richer datasets may present challenge

In comparison to bulk sequencing, single-cell sequencing methods generate datasets that are more complex and richer. The increased complexity might result in misunderstandings and wrong conclusions. However, advances in data analytics as well as the use of machine learning/AI to data analysis are increasingly being used to overcome these challenges.

Regional Adoption: Single-Cell Analysis Market

Comprehensive regional assessment of the global single-cell analysis market suggests that US is currently the largest market for single-cell analysis. The U.S. has a large number of biotech companies and research institutions, and it enjoys greater funding for life science research. Also, the U.S. led global VC investment in biotech sector in 2020, followed by Europe and China. The Asia-Pacific single-cell analysis market dominated by China is expanding more quickly compared to other regions.

Competitive Landscape Analysis of Single-Cell Analysis Market

Some of the key players in global single-cell analysis market are Becton, Dickinson and Company, Danaher, Merck, Thermo Fisher, Qiagen, 10X Genomics, Fluidigm, Promega, Illumina, Bio-Rad Laboratories, and Luminex.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com

[researchvishal]

Positron Emission Tomography (PET) Scanners Market Revenue, Future And Business Analysis By Forecast 2031

The global positron emission tomography (PET) scanners market growth was valued at over US$ 1.2 Bn in 2021 and is expected to exhibit a CAGR of close to 5.1% over the forecast period.

Key Takeaways:

By product, full-ring PET scanner is expected to hold over 86.2% of the total market share by 2031.

Sales in the oncology segment accounted for over 85.2% of market share in 2020, owing to the increasing incidence of chronic diseases and cancer.

Based on detector type, demand in the lutetium oxyorthosilicate (LSO) segment to held over 37.3% of market share in 2020.

Hospitals dominate end user segment with a share of around 34.9% in 2020 due to increasing patient inflow after COVID-19 outbreak.

The concept of PET as a nuclear medicine imaging technology was established in early 1970s. Ever since the technology has evolved into routine clinical imaging modality, revolutionizing the process of diseases diagnosis and management into more effective fashion.

PET is a molecular imaging technology that detects the concentration and pharmacokinetics of radiotracer molecules that are labelled with radioisotopes. This helps to diagnose and determine the severity of a various diseases such as neurological disorders, cardiovascular disorders, cancer, gastrointestinal and various others.

Based on the operational and geometrical capabilities of PET scanners, the systems are classified as full ring PET systems and partial ring PET systems. Advancements in technological performance of these systems are always associated with higher cost, limiting its widespread utilization in clinical PET imaging.

Rising prevalence of chronic disorders such as cancer and cardiovascular disorders, coupled with greater awareness towards physical wellbeing and limitations of conventional PET scanner is spurring demand for effective diagnostic techniques, thereby augmenting growth of the market.

PET scanners have continued to improve image quality and performance over the last few years. Technological improvements such as managing dose, reduced imaging time and enhanced lesion detectability have increased PET’s functionality, thus making it easier to interpret and diagnose various life-threatening disorders.

Key Market Segments Covered

By Product:

Full-ring PET scanner

Partial-ring PET scanner

By Application:

Oncology

Cardiology

Neurology

Others

By Detector Type:

Bismuth Germanium Oxide (BGO)

Lutetium Oxyorthosilicate (LSO)

Gadolinium Oxyorthosilicate (GSO)

Lutetium Fine Silicate (LFS)

Lutetium Yttrium Orthosilicate

By End User:

Hospitals

Diagnostic Centers

PET Centers

Research Institute

For more Information @ https://www.futuremarketinsights.com/reports/positron-emission-tomography-scanners-market 

“Ongoing technological advancements in PET scanners, copled with increasing applications in diagnostic centers and research institutes will propel the growth of the market in the forthcoming years” says a FMI analyst.

Who is winning?

Acquisitions, mergers, expansion, and product launches are the key strategies adopted by manufacturers to increase consumer base in different geographies. For instance:

In January 2020, Koninklijke Philips N.V. introduced its advanced solutions called Vereos Digital PET/CT (world’s first and only fully digital, clinically proven, PET/CT solution), an AI-powered solution for precision diagnosis at IRIA 2020.